Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab

Saved in:
Bibliographic Details
Published inPediatric nephrology (Berlin, West) Vol. 36; no. 10; pp. 3281 - 3282
Main Authors Ehren, Rasmus, Habbig, Sandra
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2021
Springer
Springer Nature B.V
Subjects
Antibodies, Monoclonal, Humanized
Atypical Hemolytic Uremic Syndrome - drug therapy
Atypical Hemolytic Uremic Syndrome - genetics
Hemolytic uremic syndrome
Humans
Letter to the Editors
Medicine
Medicine & Public Health
Nephrology
Pediatrics
Urology
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0931-041X
1432-198X
DOI:10.1007/s00467-021-05203-8